Clinical Trial Update: Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia [Phase 3]

View source ↗

Summary

This entry updates the status of a Phase 3 trial evaluating Plozasiran (ARO-APOC3) in adults with severe hypertriglyceridemia, noting the study is active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Plozasiran

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Severe Hypertriglyceridemia | Phase 3 | Status: ACTIVE_NOT_RECRUITING